Recent Advances in RP-HPLC Methods for Estimating Pharmaceutical Combinations: Focus on Tadalafil and Losartan Potassium
DOI:
https://doi.org/10.52783/jns.v14.3469Keywords:
RP-HPLC, tadalafil, losartan potassium, pharmaceutical combinations, method development, validation, drug analysis, fixed-dose combinations, bioanalytical techniquesAbstract
Recent developments in the RP-HPLC methodology aimed at determining drug combinations with special emphasis on tadalafil and losartan potassium monitoring are the subject of this research study. Tadalafil and losartan potassium receive medical usage for managing benign prostatic hyperplasia (BPH) as well as hypertension and practitioners commonly prescribe them together to treat patients with multiple health conditions. The paper demonstrates how RP-HPLC functions as the optimal analytical tool because it delivers highly precise and reproducible drug separation and quantification methods for pharmaceutical compositions. This research work provides comprehensive information about method validation parameters alongside discussions of method development including accuracy and precision alongside linearity testing and application of RP-HPLC for pharmaceutical formulations analysis. The evaluation explains analytical limitations because the technique needs both selectivity and sensitivity in drug detection along with strategies for optimization. This study concludes that RP-HPLC demonstrates successful reliability as a routine analysis method but needs additional improvements to optimize its efficiency in pharmaceutical investigations.
Downloads
Metrics
References
Lee JY, Park SY, Jeong TY, Moon HS, Kim YT, Yoo TK, et al. Combined tadalafil and α-blocker therapy for benign prostatic hyperplasia in patients with erectile dysfunction: a multicenter, prospective study. J Androl. 2012;33(3):397-403.
Hatzimouratidis K. A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction. Ther Adv Urol. 2014;6(4):135-47.
Montorsi F, Verheyden B, Meuleman E, Juenemann K-P, Moncada Iribarren I, Valiquette L, et al. Long-Term Safety and Tolerability of Tadalafil in the Treatment of Erectile Dysfunction. European urology. 2004;45:339-44; discussion 44.
Roehrborn C, Siami P, Barkin J, Damião R, Major-Walker K, Morrill B, et al. The Effects of Dutasteride, Tamsulosin and Combination Therapy on Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia and Prostatic Enlargement: 2-Year Results From the CombAT Study. The Journal of urology. 2008;179:616-21; discussion 21.
D'Atri V, Murisier A, Fekete S, Veuthey J-L, Guillarme D. Current and future trends in reversed-phase liquid chromatography-mass spectrometry of therapeutic proteins. TrAC Trends in Analytical Chemistry. 2020;130:115962.
Yabré M, Ferey L, Somé IT, Gaudin K. Greening Reversed-Phase Liquid Chromatography Methods Using Alternative Solvents for Pharmaceutical Analysis. Molecules. 2018;23(5):1065.
Rajeshwari M, A C, Rama K. VALIDATED RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF TADALAFIL AND DAPOXETINE HYDROCHLORIDE IN COMBINED PHARMACEUTICAL DOSAGE FORMS. 2014:2230-7605.
Kass D, Champion H, Beavo J. Phosphodiesterase Type 5 Expanding Roles in Cardiovascular Regulation. Circulation research. 2007;101:1084-95.
Erős D, Csaba S-K, Kiss R, Kéri G, Hegymegi-Barakonyi B, Kövesdi I, et al. Structure – Activity Relationships of PDE5 Inhibitors (Supporting Material). Current medicinal chemistry. 2008;15:1570-85.
Remuzzi G, Perico N, Macia M, Ruggenenti P. The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney International. 2005;68:S57-S65.
Ferdinand KC. A Review of the Antihypertensive and Renal-protective Effects of Irbesartan. US Cardiology 2010;7(2):25–33. 2010.
Ripley E, and Hirsch A. Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients? International Journal of Nephrology and Renovascular Disease. 2010;3(null):93-8.
Hossen M, Haque M, Dewan I, Kabir A, Hossain M, Islam A. Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Hydrochlorothiazide and Losartan Potassium in Tablet Dosage Form. Dhaka University Journal of Pharmaceutical Sciences. 2011;10.
Bhimireddy A, Shanmukha Kumar JV, Prasada Reddy Chittireddy HN, Rafi Shaik M, Assal ME, Khan M. Safety and human health: The landscape of an effective UPLC-MS/MS method for the identification and quantification of N-Nitroso Hydrochlorothiazide impurity in Hydrochlorothiazide. Journal of King Saud University - Science. 2024;36(9):103349.
Madane V, Bhatia N, Bhagwat DD. DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF TADALAFIL. WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. 2015;10:1302.
Samala A, Pawar S, Manala S, Chada S, Nageshwar M. RP-HPLC method development and validation of tadalafil in tablet dosage form. Journal of Chemical and Pharmaceutical Research. 2013;5:315-8.
Pawar H, Lalitha KG. Development and Validation of a Novel RP-HPLC Method for Estimation of Losartan Potassium in Dissolution Samples of Immediate and Sustained Release Tablets. Chromatography Research International. 2014;2014:1-8.
Rao K, Srinivas K. RP-HPLC Method for the Determination of Losartan Potassium and Ramipril in Combined Dosage Form. Indian journal of pharmaceutical sciences. 2010;72:108-11.
Dong M, Boyes BE. Modern trends and best practices in mobile-phase selection in reversed-phase chromatography. LC-GC Europe. 2018;31:572-83.
D’Atri V, Imiołek M, Quinn C, Finny A, Lauber M, Fekete S, et al. Size exclusion chromatography of biopharmaceutical products: From current practices for proteins to emerging trends for viral vectors, nucleic acids and lipid nanoparticles. Journal of Chromatography A. 2024;1722:464862.
Ghanjaoui M. High performance liquid chromatography quality control. International Journal of Advanced Chemistry. 2020:160-9.
Mochamad L, Hermanto B. High-performance liquid chromatography ultraviolet-photodiode array detection method for aflatoxin B(1) in cattle feed supplements. Vet World. 2017;10(8):932-8.
Keem M-J, Seo S-W, Kim T, Jo B-G, Kim S-N, Yoon I-S, et al. A High-Performance Liquid Chromatography with Photodiode Array Detection Method for Simultaneous Determination of Three Compounds Isolated from Wikstroemia ganpi: Assessment of the Effects on Cytochrome P450-Mediated Metabolism In Vitro and In Vivo. Nutrients. 2023;15(18):4061.
Hameedat F, Hawamdeh S, Alnabulsi S, Zayed A. High Performance Liquid Chromatography (HPLC) with Fluorescence Detection for Quantification of Steroids in Clinical, Pharmaceutical, and Environmental Samples: A Review. Molecules. 2022;27(6).
Baeza-Baeza JJ, Ortiz-Bolsico C, García-Alvarez-Coque MC. Prediction of Peak Shape and Characterization of Column Performance in Liquid Chromatography as a Function of Flow Rate. Chromatography. 2015;2(4):625-41.
Baeza-Baeza J, Ortiz-Bolsico C, García-Álvarez-Coque M. Prediction of Peak Shape and Characterization of Column Performance in Liquid Chromatography as a Function of Flow Rate. Chromatography. 2015;2:625-41.
Saha M, Gupta A, Shetty S, Mutalik S, Nandakumar K, Raghu Chandrashekar H, et al. DoE-Aided Optimization of RP-HPLC Method for Simultaneous Estimation of Amoxicillin and Tinidazole Loaded Mucoadhesive GRDDS Formulation for the Treatment of H. pylori. Chromatographia. 2024;87(9):533-48.
P.B P, Rana B, Pulusu VS, Mishra A. Multipurpose RP-HPLC Method for Simultaneous Estimation of Fixed-Dose Combinations of Anti-diabetic Drugs: Integrating Green, Economical, and Robust Approaches with Design of Experiments and White Analytical Chemistry. Chemistry Africa. 2023;7.
Prajapati P, Rana B, Pulusu VS, Mishra A. Multipurpose RP-HPLC Method for Simultaneous Estimation of Fixed-Dose Combinations of Anti-diabetic Drugs: Integrating Green, Economical, and Robust Approaches with Design of Experiments and White Analytical Chemistry. Chemistry Africa. 2024;7(3):1385-400.
Bocian S, and Krzemińska K. The separations using pure water as a mobile phase in liquid chromatography using polar-embedded stationary phases. Green Chemistry Letters and Reviews. 2019;12(1):69-78.
Rouzo G, Lamouroux C, Bresson C, Guichard A, Moisy P, Moutiers G. Hydrophilic interaction liquid chromatography for separation and quantification of selected room-temperature ionic liquids. Journal of chromatography A. 2007;1164:139-44.
Yabré M, Ferey L, Somé IT, Gaudin K. Greening Reversed-Phase Liquid Chromatography Methods Using Alternative Solvents for Pharmaceutical Analysis. Molecules. 2018;23(5).
Schieppati D, Patience NA, Campisi S, Patience GS. Experimental methods in chemical engineering: High performance liquid chromatography—HPLC. The Canadian Journal of Chemical Engineering. 2021;99(8):1663-82.
Surwase BH, Tapkir A, Jadhav SB, Chaudhari PD. Development and validation of RP-HPLC method for simultaneous estimation of telmisartan and clorthalidone in bulk and tablet dosage form. Der Pharmacia Lettre. 2013;5:149-54.
Mistry RP, Shah C, Jat R. RP-HPLC method development and validation for simultaneous estimation of telmisartan, rosuvastatin calcium, and amlodipine besylate in combination. Folia Medica. 2022;64(1):103-9.
Rao KS, Srinivas K. RP-HPLC Method for the Determination of Losartan Potassium and Ramipril in Combined Dosage Form. Indian J Pharm Sci. 2010;72(1):108-11.
Karavadi T, Challa B. Determination of Tadalafil in rat plasma by liquid chromatography tandam mass spectrometry: Application to a pharmacokinetic study. Der Pharmacia Lettre. 2012;4:1401-13.
Bhadoriya A, Dasandi B, Parmar D, Shah PA, Shrivastav PS. Quantitation of tadalafil in human plasma using a sensitive and rapid LC-MS/MS method for a bioequivalence study. Journal of Pharmaceutical Analysis. 2018;8(4):271-6.
Abdel-Aziz AAM, Asiri YA, El-Azab AS, Al-Omar MA, Kunieda T. Chapter 8 - Tadalafil. In: Brittain HG, editor. Profiles of Drug Substances, Excipients and Related Methodology. 36: Academic Press; 2011. p. 287-329.
Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev. 2008;29 Suppl 1(Suppl 1):S49-52.
Woolley CF, Hayes MA, Mahanti P, Douglass Gilman S, Taylor T. Theoretical limitations of quantification for noncompetitive sandwich immunoassays. Anal Bioanal Chem. 2015;407(28):8605-15.
Khan Z, Surana SJ, Shirkhedkar A. Studies on HPTLC and RP-HPLC methods for determination of tadalafil in pharmaceutical dosage form. INDIAN DRUGS. 2016;53:38-46.
Sonawane PH, Panzade PS, Kale MA. Rapid Estimation of Tadalafil by Reverse-phase High-performance Liquid Chromatography Method in Bulk and Tablet Formulation. Indian J Pharm Sci. 2013;75(2):230-3.
Celia C, Di Marzio L, Locatelli M, Ramundo P, D’Ambrosio F, Tartaglia A. Current Trends in Simultaneous Determination of Co-Administered Drugs. Separations. 2020;7(2):29.
Chen Y, Cui S, Lin H, Xu Z, Zhu W, Shi L, et al. Losartan improves erectile dysfunction in diabetic patients: a clinical trial. Int J Impot Res. 2012;24(6):217-20.
Chrysant S. Antihypertensive therapy causes erectile dysfunction. Current opinion in cardiology. 2015;30:383-90.
Kumar S, Basu M, Ghosh P, Pal U, Ghosh MK. COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery. Genes Dis. 2023;10(4):1402-28.
Ganji S, Satyavati D. Development and validation of RP-HPLC method for the analysis of Cobicistat and related impurities in bulk and pharmaceutical dosage forms. Asian Journal of Pharmaceutical Analysis. 2015;5.
Nyarko S, Ofori-Kwakye K, Johnson R, Kuntworbe N, Otu DAB, Yar DD, et al. Development of the RP-HPLC Method for Simultaneous Determination and Quantification of Artemether and Lumefantrine in Fixed-Dose Combination Pharmaceutical Dosage Forms. Adv Pharmacol Pharm Sci. 2024;2024:3212298.
Suhagia D, Shah R, Patel DM. Development of a RP-HPLC Method for evaluating losartan potassium and hydrochlorthiazide tablets. Indian Journal of Pharmaceutical Sciences. 2005;67:37-42.
Hafez H. Stability Indicating HPLC Method for Simultaneous Determination of Several Angiotensin-II-Receptor Antagonists in Their Dosage Forms. Pharmaceutica Analytica Acta. 2012;3:1.
Dabhi B, Jadeja Y, Patel M, Jebaliya H, Karia D, Shah A. Method Development and Validation of a Stability-Indicating RP-HPLC Method for the Quantitative Analysis of Dronedarone Hydrochloride in Pharmaceutical Tablets. Sci Pharm. 2013;81(1):115-22.
Pardhi V, Pant G, Flora SJS. RP-HPLC method development and validation for bedaquiline fumarate to evaluate its forced degradation behaviour and stability in official dissolution media. Future Journal of Pharmaceutical Sciences. 2020;6(1):42.
Hong DD, Shah M. Development and Validation of HPLC Stability-Indicating Assays. Drug Stability-Principle & Practice. 2000.
Mehta M, Mehta D, Mashru R. Recent application of green analytical chemistry: eco-friendly approaches for pharmaceutical analysis. Future Journal of Pharmaceutical Sciences. 2024;10(1):83.
Kumar D, Kumar A, Kumar V, Raj A, Rai R, Baliyan V, et al. A Comprehensive Review on Analytical Method Development using RP-HPLC and Recent Advances in Pharmaceutical Applications. Journal for Research in Applied Sciences and Biotechnology. 2023;2:53-60.
Patel M, Kumar R, Kishor K, Mlsna T, Pittman CU, Jr., Mohan D. Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods. Chemical Reviews. 2019;119(6):3510-673.
Giron D. Applications of Thermal Analysis and Coupled Techniques in Pharmaceutical Industry. Journal of Thermal Analysis and Calorimetry. 2002;68:335-57.
Wesolowski M, Leyk E. Coupled and Simultaneous Thermal Analysis Techniques in the Study of Pharmaceuticals. Pharmaceutics. 2023;15(6).
Srinivasulu D, Sastry BS, Sunil SA, Ramana H. Reverse phase HPLC method for the analysis of anastrazole in pharmaceutical dosage forms. International Journal of Pharmacy and Pharmaceutical Sciences. 2010;2:75-6.
Osman M, Abboud H, Al-Mardini M. Development and validation of RP-HPLC method for the estimation of telmisartan in bulk and pharmaceutical formulation. International Journal of Pharmaceutical Sciences Review and Research. 2013;21:34-7.
Chaudhari VS, Borkar RM, Murty US, Banerjee S. Analytical method development and validation of reverse-phase high-performance liquid chromatography (RP-HPLC) method for simultaneous quantifications of quercetin and piperine in dual-drug loaded nanostructured lipid carriers. Journal of Pharmaceutical and Biomedical Analysis. 2020;186:113325.
Kaur G, Bashir A, Gulati P. Advancements in RP-HPLC: A Review on the Simultaneous Determination of Simvastatin and Celecoxib in Plasma. Journal of Neonatal Surgery. 2025;14(13S):188-99.
Nikolaou P, Papoutsis I, Athanaselis S, Alevisopoulos G, Khraiwesh A, Pistos C, et al. Development and validation of a GC/MS method for the determination of tadalafil in whole blood. Journal of pharmaceutical and biomedical analysis. 2011;56:577-81.
Nikolaou P, Papoutsis I, Athanaselis S, Alevisopoulos G, Khraiwesh A, Pistos C, et al. Development and validation of a GC/MS method for the determination of tadalafil in whole blood. J Pharm Biomed Anal. 2011;56(3):577-81.
Bakris GL. Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker. J Clin Hypertens (Greenwich). 2008;10(1 Suppl 1):27-32.
Karmakar P, Chandra A. Combination Therapy in Management of Hypertension. 2021.
Guerrero-García C, Rubio-Guerra AF. Combination therapy in the treatment of hypertension. Drugs Context. 2018;7:212531.
Girase A, Mahale B, Dhankani A, Pawar S. Review On: RP-HPLC. 2024:21-7.
Görög S. Drug safety, drug quality, drug analysis. Journal of pharmaceutical and biomedical analysis. 2007;48:247-53.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
